Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Fulcrum Therapeutics Inc FULC

Healthcare Biotechnology
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecules to improve the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its clinical-stage product candidate is pociredir, a fetal hemoglobin inducer, which is in phase 1b clinical trial for the treatment of sickle cell disease and beta... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:FULC)

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire 1 day ago

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

GlobeNewswire 4 days ago

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

GlobeNewswire 11 days ago

Fulcrum Therapeutics Announces Positive 12-Week Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

GlobeNewswire 11 days ago

Fulcrum Therapeutics to Present 12-Week Data from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease

GlobeNewswire February 17, 2026

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 6, 2026

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 9, 2026

Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 7, 2026

Fulcrum Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire December 10, 2025
View More News ››

Opinion & Analysis (NDAQ:FULC)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:FULC)

Buy buddy buy.

Otherwise FOMO
coolfooldumbguy - November 19, 2025

Using technical analysis for this stock.

BUY buddy buy because it's going up this morning and so FOMO for you fellas out there
coolfooldumbguy - July 29, 2025

FULC .... New new N.H.O.D ; )

read my previous posts Is it time for "The Gap Fill" ?
Iseneschal - August 23, 2023

FULC ..... New N.H.O.D.... $6.22

and climbing
Iseneschal - August 23, 2023

FULC ..... N.H.O.D

Get ready ...cause here it comes
Iseneschal - August 23, 2023

FULC ....ur gold if you bot ystrdays dip

Ya never know when this could pop bigtime GLTA
Iseneschal - August 23, 2023
View more Bullboard ››

Geodrill Limited

Geodrill Limited

Geodrill Limited, together with its subsidiaries, provides mineral exploration drilling services to the mining companies in ...
View More »

Podcasts